Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2020 - 2026)

Maravai Lifesciences Holdings' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$541000.0 for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 140.44% year-over-year to -$541000.0; the TTM figure through Mar 2026 stood at -$864000.0 (up 45.93% YoY), while the FY2024 annual figure was $1.3 million, down 67.26% from the prior year.
• Gains from Investment Securities was -$541000.0 for Q1 2026 at Maravai Lifesciences Holdings, down from $1.3 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $2.4 million in Q3 2023 to a low of -$28.9 million in Q4 2023.
• Historically, Gains from Investment Securities has averaged -$3.2 million across 5 years, with a median of -$541000.0 in 2026.
• The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities tumbled 1298.98% in 2023, then soared 111.72% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at -$2.1 million in 2022, then sank by 1298.98% to -$28.9 million in 2023, then soared by 99.38% to -$178000.0 in 2024, then jumped by 825.28% to $1.3 million in 2025, then slumped by 141.91% to -$541000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$541000.0 (Q1 2026), $1.3 million (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.